Search Results - "Watson, David I."

Author Index.

Source: Diseases of the Esophagus. Sep2016 Supplement, Vol. 29, p163A-172A. 10p.

Mucosal impedance as a diagnostic tool for gastroesophageal reflux disease: an update for clinicians.

Authors: Marshall-Webb, Matthew Myers, Jennifer C Watson, David I et al.

Source: Diseases of the Esophagus. Sep2024, Vol. 37 Issue 9, p1-6. 6p.

Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomy.

Authors: Bulamu, Norma B. Vissapragada, Ravi Chen, Gang et al.

Source: Health & Quality of Life Outcomes. 10/2/2021, Vol. 19 Issue 1, p1-11. 11p.

Multi-omics evaluation of peritoneal fluid in gastroesophageal cancer (OMEGCA): protocol for a prospective multicentre cohort study to detect occult peritoneal metastases in patients undergoing curative-intent treatment.

Authors: Liu, David S. Allan, Zexi Tie, Jeanne et al.

Source: PLoS ONE. 4/16/2025, Vol. 20 Issue 4, p1-14. 14p.

iCare – a self-directed, interactive online program to improve health and wellbeing for people living with upper gastrointestinal or hepato-pancreato-biliary cancers, and their informal carers: the study protocol for a Phase II randomised controlled trial

Authors: Livingston, Patricia M Winter, Natalie Ugalde, Anna et al.

Source: BMC Cancer. 1/29/2024, Vol. 24 Issue 1, p1-10. 10p.

Spatial intra-tumour heterogeneity and treatment-induced genomic evolution in oesophageal adenocarcinoma: implications for prognosis and therapy.

Authors: Brosda, Sandra Aoude, Lauren G. Bonazzi, Vanessa F. et al.

Source: Genome Medicine. 7/17/2024, Vol. 16 Issue 1, p1-16. 16p.

A Method for Increasing the Robustness of Stable Feature Selection for Biomarker Discovery in Molecular Medicine Developed Using Serum Small Extracellular Vesicle Associated miRNAs and the Barrett's Oesophagus Disease Spectrum.

Authors: Mayne, George C. Woodman, Richard J. Watson, David I. et al.

Source: International Journal of Molecular Sciences. Apr2023, Vol. 24 Issue 8, p7068. 16p.

Research protocol for the Paraesophageal hernia symptom tool, a prospective multi-center cohort study to identify the need and threshold for surgery and assess the symptom response to surgery.

Authors: Menon, Nainika Guidozzi, Nadia Chidambaram, Swathikan et al.

Source: Diseases of the Esophagus. Oct2023, Vol. 36 Issue 10, p1-6. 6p.

Safety and Early Clinical Outcomes Following Repair of Very Large Hiatus Hernia in Octogenarians.

Authors: Watson, David I. Amprayil, Mathew A. Thompson, Sarah K. et al.

Source: World Journal of Surgery. Jan2026, Vol. 50 Issue 1, p266-267. 2p.

Computing lifetime incidence of esophageal adenocarcinoma and age-specific prevalence of Barrett's esophagus.

Authors: Vissapragada, Ravi Bulamu, Norma B Whiteman, David C et al.

Source: Diseases of the Esophagus. Jun2025, Vol. 38 Issue 3, p1-10. 10p.

A Clinical Validation of a Diagnostic Test for Esophageal Adenocarcinoma Based on a Novel Serum Glycoprotein Biomarker Panel: PromarkerEso.

Authors: Sheahan, Jordana Wang, Iris Galettis, Peter et al.

Source: Proteomes. Jun2025, Vol. 13 Issue 2, p23. 13p.

Even in Australia and Aotearoa New Zealand, High‐Volume Centres Deliver Best Outcomes for Oesophagectomy—Can We Ignore the Evidence?

Authors: Watson, David I. Petric, Josipa Ahmed, Muktar

Source: ANZ Journal of Surgery. Sep2025, Vol. 95 Issue 9, p1649-1650. 2p.

Oestrogen Receptor Isoforms May Represent a Therapeutic Target in Oesophageal Adenocarcinoma.

Authors: Due, Steven L. Watson, David I. Bastian, Isabell et al.

Source: Cancers. Apr2022, Vol. 14 Issue 8, p1891. 16p.

Lessons from a population‐based bladder cancer registry: exploring why survival is not improving.

Authors: Tempo, Jake A. Sii, Samuel Ischia, Joseph et al.

Source: BJU International. Jun2024, Vol. 133 Issue 6, p699-708. 10p.

Radical cystectomy mortality in older patients: a systematic review and meta‐analysis.

Authors: Tempo, Jake Felemban, Sulleyman Qin, Kirby R. et al.

Source: BJU International. Jul2025, Vol. 136 Issue 1, p19-31. 13p.

Para-conduit diaphragmatic hernia following esophagectomy—the new price of minimally invasive surgery?

Authors: Silva, Inoka De Wee, Melissa Cabalag, Carlos S et al.

Source: Diseases of the Esophagus. May2023, Vol. 36 Issue 5, p1-7. 7p.

Quality of life and symptom assessment in paraesophageal hernias: a systematic literature review of reporting standards.

Authors: Patel, Nikhil M Puri, Aiysha Sounderajah, Viknesh et al.

Source: Diseases of the Esophagus. Jul2021, Vol. 34 Issue 7, p1-10. 10p.

Pathological response guides adjuvant 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy in surgically resected gastro-oesophageal cancer (SPACE-FLOT): international cohort study.

Authors: Liu, David S Lee, Margaret M Hall, Katheryn et al.

Source: British Journal of Surgery. Apr2025, Vol. 112 Issue 4, p1-11. 11p.

MicroRNA-196a & microRNA-101 expression in Barrett's oesophagus in patients with medically and surgically treated gastro-oesophageal reflux.

Authors: Haiart, Sebastien Watson, David I. Leong, Mary P. et al.

Source: BMC Research Notes. 2011, Vol. 4 Issue 1, p41-46. 6p.

Endoscopic Antireflux Surgery: Are We There Yet?

Authors: Watson, David I.¹ david.watson@flinders.edu.au

Source: World Journal of Surgery. Aug2008, Vol. 32 Issue 8, p1578-1580. 3p.